Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from Transcriptomics

Cells(2021)10.3390/cells10020321Source: DataRank Database

TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from Transcriptomics is a research paper published in Cells (2021). On theSindex it has a DataRank of 0. It has been cited 84 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access84 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (28)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Heng Du ORCID,Feng Xue ORCID

Live enrichment

PubMed:33557250 PMC:PMC7913972

National Institutes of Health

Grant: R00AG037716

National Institutes of Health

Grant: R01AG053588

National Institutes of Health

Grant: R01AG059753

Alzheimer’s Association

Grant: AARG-16-442863

National Institutes of Health

Grant: 5R01AG053588-04

Mitochondrial ATP Synthase Dysfunction and Synaptic Stress in Alzheimer's Disease

National Institutes of Health

Grant: 5R01AG059753-06

GHSR1a and Hippocampal Pathology in Alzheimer's Disease

goldLicense: cc-by

publisherhttps://www.mdpi.com/2073-4409/10/2/321/pdf?version=1612670243

publisherhttps://www.mdpi.com/2073-4409/10/2/321/pdf

repositoryhttps://doaj.org/article/6b31ba355051443eb19bc6ff5676592a

repositoryhttp://hdl.handle.net/1808/32373

repositoryhttps://dx.doi.org/10.3390/cells10020321

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

MicrogliaAnimalsHumansAlzheimer DiseaseMembrane GlycoproteinsAnti-Inflammatory AgentsGene Regulatory NetworksTranscriptome

Keywords

MicrogliaAlzheimer’s diseaseneuroinflammationTranscriptomicsTrem2/trem2570Membrane GlycoproteinsQH573-671Anti-Inflammatory Agents610ReviewAlzheimer DiseaseAnimalsHumansGene Regulatory NetworksCytologyTranscriptome

Sustainable Development Goals

SDG 3: 3. Good healthSDG 14: 14. Life underwater

Additional file 18 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555723figshare

Additional file 14 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555711.v1figshare

Additional file 10 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555699figshare

Additional file 15 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555714.v1figshare

Additional file 9 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555696.v1figshare

Additional file 2 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555675.v1figshare

Additional file 7 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555690figshare

Additional file 18 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555723.v1figshare

Additional file 17 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555720figshare

Additional file 1 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555672.v1figshare

Additional file 16 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555717figshare

Additional file 6 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555687.v1figshare

Additional file 9 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555696figshare

Additional file 16 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555717.v1figshare

Additional file 15 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555714figshare

Additional file 13 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555708figshare

Additional file 14 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555711figshare

Additional file 17 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555720.v1figshare

Additional file 6 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555687figshare

Additional file 5 of Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

10.6084/m9.figshare.26555684.v1figshare

Related Papers (6)

Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes

N/A

0.852DataRank · unranked

Nature Medicine(2020)

co-cited

10.1038/s41591-020-0886-4

The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease

N/A

8.5DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2681-2

Impact of TREM2R47H variant on tau pathology–induced gliosis and neurodegeneration

Journal of Clinical Investigation(2020)

co-cited

10.1172/jci138179

β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia

Cell Reports(2020)

co-cited

10.1016/j.celrep.2020.02.025

The role of innate immunity in Alzheimer's disease

N/A

3.0DataRank · unranked

Immunological Reviews(2020)

co-cited

10.1111/imr.12896

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

N/A

7.1DataRank · unranked

Frontiers in Immunology(2020)

co-cited

10.3389/fimmu.2020.00456

TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from Transcriptomics

FAIR Checklist

Authors (2)

Funding (6 grants)

Open Access

Topics

Linked Datasets (25)

Annotations (Europe PMC)

Related Papers (6)